Mineralys Therapeutics News

Mineralys Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Rodman David Malcom

Apr 15 16:29 ET

Mineralys Therapeutics | EFFECT: Others

Apr 12 06:07 ET

Mineralys Therapeutics | 424B5: Prospectus

Apr 11 16:42 ET

Mineralys Therapeutics | ARS: Annual Report to Security Holders

Apr 9 07:24 ET

Mineralys Therapeutics | DEFA14A: Others

Apr 9 07:20 ET

Mineralys Therapeutics | DEF 14A: Definitive information statements

Apr 9 07:19 ET

Mineralys Therapeutics | 8-K: Current report

Apr 4 08:05 ET

Mineralys Therapeutics | S-3/A: Registration statement for specified transactions by certain issuers (Amendment)

Mar 29 16:48 ET

Mineralys Therapeutics | 8-K: Mineralys Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update

Mar 21 07:46 ET

Mineralys Therapeutics | S-3: Registration statement for specified transactions by certain issuers

Mar 21 07:36 ET

Mineralys Therapeutics | 10-K: Annual report

Mar 21 07:21 ET

Mineralys Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Rodman David Malcom

Mar 13 17:40 ET

Mineralys Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Rodman David Malcom

Feb 15 16:28 ET

Mineralys Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Levy Adam Scott

Feb 15 16:28 ET

Mineralys Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Congleton Jon

Feb 15 16:28 ET

Mineralys Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-TCG Crossover GP II, LLC(6.4%),TCG Crossover Fund II, L.P.(6.4%), etc.

Feb 15 16:23 ET

Mineralys Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director AKKARAJU SRINIVAS

Feb 14 21:08 ET

Mineralys Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Samsara BioCapital GP, LLC

Feb 14 21:08 ET

Mineralys Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director RA CAPITAL MANAGEMENT, L.P.

Feb 14 19:53 ET

Mineralys Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Adams Street Partners, LLC(5.60%),Adams Street Growth Equity Fund VII LP(2.17%), etc.

Feb 14 06:07 ET